Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Rangering i aksjer #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Aksjekurs
$0.09933121
Markedsverdi
$29.15K
Endring (1 dag)
0.57%
Endring (1 år)
449.49%
Land
IE
Handel Ovoca Bio plc (OVB)

Kategori

EPS for Ovoca Bio plc (OVB)
EPS per June 2024 TTM: $-0.07
Ifølge de siste økonomiske rapportene og aksjekursen til Ovoca Bio plc er selskapets nåværende EPS (TTM) $-0.07. Ved slutten av 2023 hadde selskapet en EPS på $-0.08, en økning sammenlignet med EPS-en i 2022 som var $-0.07.
EPS-historikk for Ovoca Bio plc fra 2001 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-0.07 -100.00%
2024 0.00 -100.00%
2023 $-0.08 1.90%
2022 $-0.07 -3.28%
2021 $-0.08 119.25%
2020 $-0.03 61.86%
2019 $-0.02 -35.24%
2018 $-0.03 492.86%
2017 $-0.01 -54.84%
2016 $-0.01 -57.97%
2015 $-0.03 -67.97%
2014 $-0.09 -60.61%
2013 $-0.23 595.83%
2012 $-0.03 -153.50%
2011 $0.06 -220.77%
2010 $-0.05 -257.10%
2009 $0.03 -124.09%
2008 $-0.14 646.74%
2007 $-0.02 -87.28%
2006 $-0.14 210.52%
2005 $-0.05 9.39%
2004 $-0.04 0.00%
2003 $-0.04 92.76%
2002 $-0.02 -23.26%
2001 $-0.03 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$3.62 -5,152.02%
DK
$15.47 -21,676.01%
US
$43.12 -60,239.47%
US
$9.62 -13,518.13%
BE
$38.32 -53,544.91%
NL